05:58 PM EDT, 07/22/2024 (MT Newswires) -- Azenta ( AZTA ) late Monday said it is participating in the FinnGen study project, expecting to collect and analyze genomic and health data from a group of 500,000 Finnish biobank participants.

The project is in collaboration with the University of Helsinki which is leading the study.

Azenta ( AZTA ) will provide proteomics profiling on as many as 20,000 people. The company will use advanced proteomics technology to provide high-quality protein-level measurements across all major biological pathways.

Price: 58.00, Change: +0.23, Percent Change: +0.40